⌕
GRAIL · GRAL · Nasdaq
Tenet 63 · Solid
Compare
$115.89−4.50%At closeTenet 63 · Solid
$115.89−5.46 (−4.50%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

GRAIL (GRAL) Stock

GRAIL (GRAL) closed at $115.89 on Nov 13, 2026; its Tenet Score is 63 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

23 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$115.89
Nov 13, 2026
Market cap
$5.2B
share price × the latest quarter's diluted weighted-average share count (vendor)
52-week range
41.50 – 166.47
low → high
Tenet Score
63/100
Solid · 409 Healthcare peers

Industry: Health Services · see every company filed here →

GRAIL Inc. scores 63/100. Solid. Strongest on financial health and value, quality is the soft spot versus 409 Healthcare peers.

Tenet Score · vs sector

n=409
63/ 100
Solid
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
75
Quality
39
Health
82
Growth
55

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueBQualityDHealthBGrowthCMomentumB
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
2.1×
price to book value
P/S
31.3×
price to fiscal 2025 sales
ROE
−17%
return on equity
Operating margin
−382.0%
fiscal 2025, before interest and tax
Net margin
−243.8%
of revenue kept
Current ratio
8.93
current assets to liabilities
Net debt / EBITDA
—
Not meaningful: EBITDA is zero or negative.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About GRAIL Inc.

GRAIL, LLC, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate di…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 86 US ETFs · top wrappers by weightSee all ETFs holding GRAL →

Similar-sized companies in Health Services

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is GRAIL in?

GRAIL is in the Healthcare sector and the Health Services industry.

What is GRAIL's Tenet Score?

GRAIL's Tenet Score is 63 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.